CLASS II ONGOING Device recall · Reported 5 Nov 2025 · FDA Enforcement Report

Greiner Bio-one Vacuette 9NC Coagulation sodium citrate recalled

Greiner Bio-One North America is recalling Greiner Bio-one Vacuette 9NC Coagulation sodium citrate 3.2%, distributed nationwide in the US. The recall was initiated on 8 Aug 2025 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesUDI-DI: 29120017574488(Rack), 39120017574485(Case). Lot: B250139Q, Expiration: 01/09/2026
Quantity recalled504,000

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0408-2026
FDA event ID
97457
Recalling firm
Greiner Bio-One North America, Monroe, NC
Classification
Class II
Status
Ongoing
Recall initiated
8 Aug 2025
FDA classified
28 Oct 2025
Reported
5 Nov 2025
Type
Voluntary: Firm initiated
Customers notified by
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Reason category
Other Reasons

Timeline

8 Aug 2025Recall initiated by company
28 Oct 2025Classified by FDA+81 days
5 Nov 2025Published in enforcement report+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Blood collection tubes were manufactured with the label applied too high on the tube, which shifted the printed fill level mark upward, which could result in unnecessary sample rejection and repeat collections.

Product as listed by the FDA

Greiner BIO-ONE VACUETTE 2 ml 9NC Coagulation sodium citrate 3.2%, REF: 454322

Where it was distributed

US Nationwide distribution.

Nationwide

Questions about this recall

Why was it recalled?

Blood collection tubes were manufactured with the label applied too high on the tube, which shifted the printed fill level mark upward, which could result in unnecessary sample rejection and repeat collections.

Which lots are affected?

UDI-DI: 29120017574488(Rack), 39120017574485(Case). Lot: B250139Q, Expiration: 01/09/2026

Where was it sold?

US Nationwide distribution.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Greiner Bio-One North America

All 16

Other Other Medical Devices recalls

All 13,908